Therapeutic Effects of Selenium-enriched rapeseed against Triple-Negative Breast Cancer: Involvement of Resolvin D5 Activation and IL-17 Signaling Inhibition

Abstract

Triple-negative breast cancer (TNBC) presents a major therapeutic challenge due to its aggressive behavior and a microenvironment characterized by oxidative stress and chronic inflammation. As a selenium-biofortified edible vegetable, selenium-enriched rapeseed shoots (SeRS) are a promising dietary source of methylselenocysteine (MSC), highlighting their potential in "medicine-food homology" strategies. Prior work has demonstrated that SeRS exhibits both antioxidant and anti-inflammatory properties, its precise role as a dietary intervention in modulating the redox-inflammatory axis in TNBC remains unclear. To investigate this, we evaluated the chemo-preventive efficacy of SeRS and its underlying mechanism. Our data indicate a potent inhibitory effect of the SeRS aqueous extract on both the migration and invasion of TNBC cells in a cell-based assay. In a preventive dietary regimen using a 4T1 syngeneic mouse model, SeRS potently suppressed tumor growth. Integrated metabolomic and transcriptomic analyses identified resolvin D5 (RvD5), a specialized pro-resolving mediator, as a key endogenous metabolite upregulated by SeRS, and revealed the pro-oxidant interleukin IL-17 signaling pathway as a potential target. Molecular docking confirmed high-affinity binding between RvD5 and IL-17A. Functionally, both SeRS and purified RvD5 suppressed IL-17 pathway activation, as evidenced by reduced p65 phosphorylation and downregulation of IL-17RA and ACT-1. Rescue experiments demonstrated that RvD5 could counteract IL-17A-induced tumor progression. Our findings elucidate a coordinated mechanism in which SeRS, via upregulation of RvD5, suppresses the IL-17 signaling pathway-a key driver of inflammation-associated oxidative stress-thereby exerting anti-TNBC effects. This work provides a scientific basis for developing selenium-enriched agricultural products into functional foods for cancer prevention through targeted nutritional modulation.

Supplementary files

Article information

Article type
Paper
Submitted
26 Dec 2025
Accepted
02 Apr 2026
First published
08 Apr 2026
This article is Open Access
Creative Commons BY-NC license

Food Funct., 2026, Accepted Manuscript

Therapeutic Effects of Selenium-enriched rapeseed against Triple-Negative Breast Cancer: Involvement of Resolvin D5 Activation and IL-17 Signaling Inhibition

Y. Lin, T. Wang, Z. Wu, L. Wang, Z. Yu, J. Wang, T. Liu, X. Cai, H. Li, Y. Ren, Z. Su, S. Zhang, J. An, Q. Wu and H. Wang, Food Funct., 2026, Accepted Manuscript , DOI: 10.1039/D5FO05648A

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements